Abivax will present nine scientific abstracts on obefazimod at Digestive [...]
Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]
Investment led by aMoon will support US and EU commercialisation [...]
QuantHealth has simulated more than 350 clinical trials using its [...]
NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Bringing you the latest industry news and insights every day
Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596
© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design
